D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
RXDX holding history
Prometheus Biosciences, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RXDX overviewAll 13F holders of RXDXFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −797,567−100.0% | Sold out | Holders |
| Q1 2023 | 797,567 | $85.6M | 0.1% | +72,338+10.0% | Added | Holders |
| Q4 2022 | 725,229 | $79.8M | 0.1% | +563,848+349.4% | Added | Holders |
| Q3 2022 | 161,381 | $9.52M | <0.1% | +117,360+266.6% | Added | Holders |
| Q2 2022 | 44,021 | $1.24M | <0.1% | −24,882−36.1% | Reduced | Holders |
| Q1 2022 | 68,903 | $2.60M | <0.1% | +52,432+318.3% | Added | Holders |
| Q4 2021 | 16,471 | $651.0K | <0.1% | +16,471 | New | Holders |